img
Effect of intravitreal aflibercept treatment on retinal vesselparameters in diabetic macular edema Arteriolarvasoconstriction     
Yazarlar
Dr. Öğr. Üyesi Mehmet Cem SABANER
Afyonkarahisar Sağlık Bilimleri Üniversitesi, Türkiye
Mustafa Doğan
Afyonkarahisar Sağlık Bilimleri Üniversitesi, Türkiye
Reşat Duman
Afyonkarahisar Sağlık Bilimleri Üniversitesi, Türkiye
Özet
To evaluate the effects of intravitreal aflibercept (IVA) treatment on retinal vein parameters and choroidal thickness used in the treatment of diabetic macular oedema (DME). This retrospective study administered Afyonkarahisar Health Sciences University Department of Ophthalmology. Twenty-nine patients who were diagnosed with naive DME in a single eye were included in the study. A three consecutive, monthly intravitreal injection of 2 mg aflibercept were administered to patients. Each patient's contralateral (untreated) eyes, which did not diagnose DME and did not receive any treatment, were the control group. The central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and artery-vein ratio (AVR) values were measured using a semi-automatically computer-based software before the first IVA injection and 30 d after the first, second, and third injections. The main outcome measurements were the central macular thickness (CMT), best-corrected visual acuity (BCVA), subfoveal choroidal thickness (sf-CT), CRAE, CRVE, and AVR. The mean age of patients was 59.25 ± 9.48 years. Patients were 15 males and 14 females. A significant vasoconstriction of the retinal arterioles, a thinning of sf-CT and CMT, and an increase of BCVA have observed in IVA-treated eyes compared to baseline (respectively,  < 0.001,  < 0.001,  < 0.001,  < 0.001). But, no significant differences were found for CRVE and AVR in IVA-treated eyes compared to baseline. No significant difference was found for all parameters in untreated eyes compared to baseline. This study demonstrates that IVA treatment can change retinal blood flow by reducing retinal artery diameter and thinning in the choroid.
Anahtar Kelimeler
Retinal vessel diameter,diabetic macular oedema,aflibercept,vasoconstriction
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı Cutaneous and Ocular Toxicology
Dergi ISSN 1556-9527
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili İngilizce
Basım Tarihi 03-2019
Doi Numarası 10.1080/15569527.2019.1594875